Поисковый запрос: (<.>A=Workman, Paul$<.>) |
Общее количество найденных документов : 27
Показаны документы с 1 по 20
|
|
1.
| Walton Molecular enzymology of the reductive bioactivation of hypoxic cell cytotoxins // 77Int. J. Radiat., Oncol. Biol., Phys., 1989. Vol. 16, N 4.-С.983-986
|
2.
| Workman Accelerated elimination of pimonidazole following microsomal enzyme induction in mice: a possible approach to reduced neurotoxicity of the pimonidazole-etanidazole combination // Int. J. Radiat., Oncol. Biol., Phys., 1989. Vol. 16, N 4.-С.1011-1013
|
3.
| Decreased NADPH: Cytochrome P-450 reductase activity and impaired drug activation in a mammalian cell line resistant to mitomycin C under aerobic but not hypoxic conditions // Cancer Res., 1990. Vol. 50, N 15.-С.4692-4697
|
4.
| Workman Micropharmacokinetics of chemical modifiers // Int. J. Radiat., Oncol. Biol., Phys., 1989. Vol. 16, N 4.-С.897-906
|
5.
| Maxwell Ross J. Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by {1}{0}F magnetic resonance spectroscopy in vivo // Int. J. Radiat., Oncol., Biol., Phys., 1989. Vol. 16, N 4.-С.425-429
|
6.
| Coley Helen M. Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A // Biochem. Pharmacol., 1989. Vol. 38, N 24.-С.4467-4475
|
7.
| Coley Helen M. 9-alkyl, morpholinyl anthracyclines in the circumvention of multidrug resistance // Eur. J. Cancer, 1990. Vol. 26, N 6.-С.665-667
|
8.
| Samant Rahul S. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to theat shock protein 90 inhibition in human cancer cells // Proc. Nat. Acad. Sci. USA, 2014. Vol. 111, N 18.-С.6834-6839
|
9.
| Samant Rahul S. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to theat shock protein 90 inhibition in human cancer cells // Proc. Nat. Acad. Sci. USA, 2014. Vol. 111, N 18.-С.6834-6839
|
10.
| Samant Rahul S. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to theat shock protein 90 inhibition in human cancer cells // Proc. Nat. Acad. Sci. USA, 2014. Vol. 111, N 18.-С.6834-6839
|
11.
| Dive Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells // Cancer Res., 1991. Vol. 51, N 3.-С.799-806
|
12.
| Workman Platelet-activating factor (PAF) antagonist WEB 2086 does not modulate the cytotoxicity of PAF or antitumour alkyl lysophospholipids ET-18-O-Methyl and SRI 62-834 in HL-60 promyelocytic leukaemia cells // Biochem. Pharmacol., 1991. Vol. 41, N 2.-С.319-322
|
13.
| Brunton Valerie G. The effect of tyrosine kinase inhibitors on EGF-dependent proliferative and phosphorylation events in human squamous carcinoma cell lines // J. Cell. Biochem., 1993, Suppl. 17А.-С.231
|
14.
| Walton Michael I. Stimulation by localized tumor hyperthermia of reductive bioactivation of 2-nitroimidazole benznidazole in mice // Cancer Res., 1989. Vol. 49, N 9.-С.2351-2355
|
15.
| Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential // Biochem. Pharmacol., 2001. Vol. 62, N 10.-С.1311-1336
|
16.
| Gene expression microarray analysis in cancer biology, pharmacology, and drug development: Progress and potential // Biochem. Pharmacol., 2001. Vol. 62, N 10.-С.1311-1336
|
17.
| Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-x[L] and increases oxaliplatin- and Fas-induced apoptosis // J. Biol. Chem., 2004. Vol. 279, N 44.-С.46113-46121
|
18.
| Phospholipid antitumor agents // Med. Res. Rev., 1995. Vol. 15, N 3.-С.157-223
|
19.
| Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554) // Biochem. Pharmacol., 1997. Vol. 54, N 11.-С.1217-1224
|
20.
| Validation of liquid chromatography assay for the quantitation of (Z)-3-[2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl]propionic acid (SU006668) in human plasma and its application to a phase I clinical trial // J Chromatogr. B, 2003. Vol. 785, N 1.-С.175-186
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"